Home treatment with enzyme replacement therapy for mucopolysaccharidosis type I is feasible and safe-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Home treatment with enzyme replacement therapy for mucopolysaccharidosis type I is feasible and safe

Published:2007-09-21 Issue:6 Volume:30 Page:984-984
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Cox-Brinkman J.,Timmermans R. G. M.,Wijburg F. A.,Donker W. E.,van de Ploeg A. T.,Aerts J. M. F. G.,Hollak C. E. M.

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10545-007-0686-8

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of MPS-I using ERT: The Egyptian experience;2023-11-16

2. Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions;BioDrugs;2023-06-16

3. Quantification of Glycosaminoglycans in Urine by Isotope‐Dilution Liquid Chromatography‐Electrospray Ionization Tandem Mass Spectrometry;Current Protocols;2023-03

4. Real-world data assessment of safety of home-based and hospital/outpatient-based laronidase enzyme replacement therapy for mucopolysaccharidosis I;Molecular Genetics and Metabolism Reports;2021-06

5. Heiminfusionstherapie bei Morbus Pompe: Konsensusempfehlungen für den deutschsprachigen Raum;Fortschritte der Neurologie · Psychiatrie;2021-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP